![](/img/cover-not-exists.png)
SKP-104, A NOVEL MODIFIED-RELEASE FORMULATION OF ZALEPLON, SIGNIFICANTLY IMPROVES SLEEP IN PATIENTS WITH MIDDLE-OF-THENIGHT AWAKENING: RESULTS OF A PHASE II, DOUBLE-BLIND, CROSSOVER, PLACEBO-CONTROLLED, DOSE-RANGING TRIAL
James K. Walsh, David Seiden, Beth Safirstein, D. Alan Lankford, Gary Zammit, Jon Freeman, Steven Hull, Russell RosenbergVolume:
12
Year:
2011
Language:
english
DOI:
10.1016/s1389-9457(11)70024-7
File:
PDF, 66 KB
english, 2011